1 Einträge von 1 mit products make
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:10
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cells chimeric | cell genetic | malignant t-cells | plasma patient | multiple therapies | myeloma bcma | antigen these | against with | rrmm their | from clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
products cause deleterious effects to organs including bones, bone marrow and the kidneys; a variety of mechanisms are postulated to be involved, including bone marrow infiltration by the abnormal cells and organ damage secondary to monoclonal protei make it an ideal drug target for RRMM. FDA approval There are two CAR-T cell therapies currently approved by the Food and Drug Administration (FDA) of the United States for the treatment of adult patients with RRMM: idecabtagene v
Text Inhalt Text aus URL
Log Metriken 12445
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cells chimeric | cell genetic | malignant t-cells | plasma patient | multiple therapies | myeloma bcma | antigen these | against with | rrmm their | from clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
products cause deleterious effects to organs including bones, bone marrow and the kidneys; a variety of mechanisms are postulated to be involved, including bone marrow infiltration by the abnormal cells and organ damage secondary to monoclonal protei make it an ideal drug target for RRMM. FDA approval There are two CAR-T cell therapies currently approved by the Food and Drug Administration (FDA) of the United States for the treatment of adult patients with RRMM: idecabtagene v
Text Inhalt Text aus URL
Log Metriken 12445